Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 9 | 2014 | 268 | 1.720 |
Why?
|
| Quality of Health Care | 8 | 2008 | 219 | 1.460 |
Why?
|
| Arkansas | 24 | 2015 | 2101 | 1.040 |
Why?
|
| Quality Indicators, Health Care | 4 | 2008 | 98 | 0.730 |
Why?
|
| Delivery of Health Care | 5 | 2008 | 325 | 0.720 |
Why?
|
| Medicare | 3 | 2006 | 245 | 0.680 |
Why?
|
| Patient-Centered Care | 2 | 2012 | 132 | 0.640 |
Why?
|
| Reimbursement Mechanisms | 3 | 2014 | 25 | 0.570 |
Why?
|
| Practice Guidelines as Topic | 6 | 2008 | 489 | 0.540 |
Why?
|
| Drug Prescriptions | 2 | 2006 | 89 | 0.520 |
Why?
|
| Reimbursement, Incentive | 2 | 2013 | 14 | 0.500 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 62 | 0.460 |
Why?
|
| Health Policy | 1 | 2014 | 171 | 0.440 |
Why?
|
| Episode of Care | 1 | 2012 | 5 | 0.440 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 28 | 0.420 |
Why?
|
| Cesarean Section | 1 | 2013 | 179 | 0.420 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2004 | 175 | 0.410 |
Why?
|
| Hypertension | 2 | 2007 | 565 | 0.400 |
Why?
|
| Adolescent Health Services | 1 | 2011 | 11 | 0.390 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 164 | 0.390 |
Why?
|
| Asthma | 3 | 2004 | 293 | 0.390 |
Why?
|
| Humans | 35 | 2015 | 54397 | 0.390 |
Why?
|
| United States | 10 | 2014 | 5209 | 0.380 |
Why?
|
| Child Health Services | 1 | 2011 | 98 | 0.360 |
Why?
|
| Drug Utilization Review | 1 | 2009 | 26 | 0.350 |
Why?
|
| Efficiency, Organizational | 2 | 2015 | 53 | 0.340 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2006 | 82 | 0.340 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 387 | 0.340 |
Why?
|
| Child Behavior Disorders | 1 | 2009 | 87 | 0.330 |
Why?
|
| Chemoprevention | 2 | 2006 | 16 | 0.320 |
Why?
|
| Efficiency | 1 | 2008 | 36 | 0.320 |
Why?
|
| Primary Health Care | 1 | 2012 | 398 | 0.320 |
Why?
|
| Total Quality Management | 1 | 2008 | 27 | 0.320 |
Why?
|
| Mental Health Services | 1 | 2011 | 233 | 0.320 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 428 | 0.310 |
Why?
|
| Benchmarking | 1 | 2008 | 73 | 0.310 |
Why?
|
| Sociology, Medical | 1 | 2007 | 3 | 0.310 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 241 | 0.300 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2006 | 24 | 0.300 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 276 | 0.290 |
Why?
|
| Polypharmacy | 1 | 2006 | 15 | 0.290 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 46 | 0.280 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 209 | 0.280 |
Why?
|
| Pharyngitis | 1 | 2006 | 17 | 0.280 |
Why?
|
| Thromboembolism | 1 | 2006 | 56 | 0.270 |
Why?
|
| Patient Compliance | 1 | 2007 | 247 | 0.270 |
Why?
|
| Diabetes Complications | 1 | 2006 | 123 | 0.270 |
Why?
|
| Pediatrics | 1 | 2009 | 323 | 0.270 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 102 | 0.260 |
Why?
|
| Benzodiazepines | 1 | 2005 | 70 | 0.260 |
Why?
|
| Bacterial Infections | 1 | 2006 | 105 | 0.260 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 86 | 0.260 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 111 | 0.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 231 | 0.250 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2005 | 38 | 0.250 |
Why?
|
| Hemophilia B | 1 | 2004 | 4 | 0.250 |
Why?
|
| Telemedicine | 1 | 2011 | 453 | 0.250 |
Why?
|
| Vaginal Smears | 1 | 2004 | 31 | 0.250 |
Why?
|
| Physicians | 1 | 2008 | 245 | 0.250 |
Why?
|
| Risk Factors | 6 | 2013 | 3937 | 0.250 |
Why?
|
| Hemophilia A | 1 | 2004 | 28 | 0.240 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 74 | 0.240 |
Why?
|
| Trust | 1 | 2004 | 64 | 0.240 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 94 | 0.230 |
Why?
|
| Anxiety | 1 | 2005 | 279 | 0.230 |
Why?
|
| Blood Pressure | 1 | 2006 | 587 | 0.230 |
Why?
|
| Renal Dialysis | 1 | 2005 | 193 | 0.230 |
Why?
|
| Community-Acquired Infections | 1 | 2003 | 42 | 0.220 |
Why?
|
| Government Regulation | 1 | 2002 | 15 | 0.220 |
Why?
|
| Referral and Consultation | 1 | 2005 | 308 | 0.220 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 79 | 0.220 |
Why?
|
| Attitude to Health | 1 | 2004 | 226 | 0.210 |
Why?
|
| Pneumonia | 1 | 2003 | 129 | 0.210 |
Why?
|
| Nursing Homes | 1 | 2002 | 126 | 0.200 |
Why?
|
| Ambulatory Care | 1 | 2003 | 231 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 276 | 0.200 |
Why?
|
| Prenatal Care | 1 | 2002 | 118 | 0.190 |
Why?
|
| Child | 6 | 2011 | 7368 | 0.190 |
Why?
|
| Program Development | 2 | 2012 | 198 | 0.170 |
Why?
|
| Patient Education as Topic | 3 | 2007 | 311 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 825 | 0.140 |
Why?
|
| Blood Specimen Collection | 1 | 2015 | 39 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2015 | 50 | 0.130 |
Why?
|
| Federal Government | 1 | 2014 | 5 | 0.120 |
Why?
|
| Uncompensated Care | 1 | 2014 | 5 | 0.120 |
Why?
|
| Economics, Hospital | 1 | 2014 | 17 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2008 | 148 | 0.120 |
Why?
|
| Financing, Government | 1 | 2014 | 25 | 0.120 |
Why?
|
| State Government | 1 | 2014 | 43 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2004 | 43 | 0.110 |
Why?
|
| Pregnancy | 3 | 2013 | 2641 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2015 | 245 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2004 | 95 | 0.110 |
Why?
|
| Poverty | 1 | 2014 | 231 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2015 | 2924 | 0.100 |
Why?
|
| Adolescent | 3 | 2011 | 6901 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2006 | 1362 | 0.100 |
Why?
|
| Consultants | 1 | 2011 | 5 | 0.100 |
Why?
|
| Neonatology | 1 | 2011 | 14 | 0.100 |
Why?
|
| Mass Screening | 2 | 2005 | 370 | 0.100 |
Why?
|
| Certification | 1 | 2011 | 47 | 0.100 |
Why?
|
| Prevalence | 1 | 2013 | 1026 | 0.090 |
Why?
|
| Female | 6 | 2013 | 28474 | 0.090 |
Why?
|
| Premature Birth | 1 | 2011 | 154 | 0.080 |
Why?
|
| Physician's Role | 1 | 2007 | 51 | 0.070 |
Why?
|
| Organizational Culture | 1 | 2007 | 46 | 0.070 |
Why?
|
| Drug Monitoring | 1 | 2007 | 85 | 0.070 |
Why?
|
| Drug Incompatibility | 1 | 2006 | 1 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 3431 | 0.070 |
Why?
|
| Psychiatry | 1 | 2008 | 116 | 0.070 |
Why?
|
| Infant | 2 | 2006 | 3830 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2006 | 4158 | 0.070 |
Why?
|
| Methylphenidate | 1 | 2007 | 94 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 134 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2006 | 89 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2006 | 75 | 0.070 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2002 | 31 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 1 | 2005 | 36 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2005 | 22 | 0.070 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2005 | 23 | 0.060 |
Why?
|
| Hemoglobin, Sickle | 1 | 2004 | 7 | 0.060 |
Why?
|
| Hemoglobin SC Disease | 1 | 2004 | 6 | 0.060 |
Why?
|
| Sickle Cell Trait | 1 | 2004 | 3 | 0.060 |
Why?
|
| Arm | 1 | 2005 | 52 | 0.060 |
Why?
|
| Radial Artery | 1 | 2005 | 38 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 54 | 0.060 |
Why?
|
| Veins | 1 | 2005 | 74 | 0.060 |
Why?
|
| Blood Coagulation Factors | 1 | 2004 | 19 | 0.060 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2005 | 67 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 255 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 119 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2004 | 73 | 0.060 |
Why?
|
| Chlamydia Infections | 1 | 2005 | 119 | 0.060 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2002 | 8 | 0.060 |
Why?
|
| Inhalation Spacers | 1 | 2002 | 8 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 223 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 26 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2002 | 32 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2004 | 270 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 570 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 76 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 426 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2004 | 614 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1082 | 0.050 |
Why?
|
| Aged | 2 | 2006 | 10061 | 0.050 |
Why?
|
| Hospitalization | 1 | 2004 | 704 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2003 | 184 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 2126 | 0.040 |
Why?
|
| Heart Failure | 1 | 2005 | 541 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 3210 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2002 | 1547 | 0.040 |
Why?
|
| Aging | 1 | 2002 | 784 | 0.040 |
Why?
|
| Male | 2 | 2004 | 27348 | 0.030 |
Why?
|
| Hospitals | 1 | 2011 | 188 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2008 | 444 | 0.020 |
Why?
|
| Durable Medical Equipment | 1 | 2002 | 4 | 0.010 |
Why?
|
| Pharmacies | 1 | 2002 | 63 | 0.010 |
Why?
|